Ambey Laboratories Ltd

AMBEYPesticides & Agrochemicals
32.00+0.00 (+0.00%)
As on 29 Jan 2026, 10:34 amMarket Closed

Fundamental Score

...

Ambey Laboratories Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

8.75%
Poor

Return on Capital Employed

9.97%
Poor

Operating Profit Margin (5Y)

8.92%
Poor

Dividend Yield

0.00%

Valuation Metrics

Good

Price to Earnings

25.31x

Market Capitalization

112.38 (Cr)

Industry P/E

29.36x

Growth Metrics

Poor

YoY Quarterly Profit Growth

-11.78%
Poor

YoY Quarterly Sales Growth

0.78%

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Financial Health

Good

Debt to Equity

0.44x
Excellent

Interest Coverage

3.92x
Poor

Free Cash Flow (5Y)

-52.92 (Cr)

Ownership Structure

Good

Promoter Holding

70.15%
Poor

FII Holding

0.00%
Poor

DII Holding

1.96%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
70.15%
Promoter Holding
112.38 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of AMBEY across key market metrics for learning purposes.

Positive Indicators

2 factors identified

Balanced Promoter Holding (70.15%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

7 factors identified

Below-Average Return on Equity (8.75%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (9.97%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Profit Decline Concern (-11.78%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.

Negative Free Cash Flow (₹-52.92 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 1.96%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Ambey Laboratories Ltd

About AMBEY

Company Details

Symbol:AMBEY
Industry:Pesticides & Agrochemicals
Sector:Pesticides & Agrochemicals
Website:N/A

AMBEY Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)8.75%
Return on Capital Employed9.97%
Operating Profit Margin (5Y)8.92%
Debt to Equity Ratio0.44
Interest Coverage Ratio3.92

Growth & Valuation

Sales Growth (5Y)N/A%
Profit Growth (5Y)N/A%
EPS Growth (5Y)N/A%
YoY Quarterly Profit Growth-11.78%
YoY Quarterly Sales Growth0.78%

Frequently Asked Questions

What is the current price of Ambey Laboratories Ltd (AMBEY)?

As of 29 Jan 2026, 10:34 am IST, Ambey Laboratories Ltd (AMBEY) is currently trading at ₹32.00. The stock has a market capitalization of ₹112.38 (Cr).

Is AMBEY share price Overvalued or Undervalued?

AMBEY is currently trading at a P/E ratio of 25.31x, compared to the industry average of 29.36x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Ambey Laboratories Ltd share price?

Key factors influencing AMBEY's price include its quarterly earnings growth (Sales Growth: 0.78%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Ambey Laboratories Ltd a good stock for long-term investment?

Ambey Laboratories Ltd shows a 5-year Profit Growth of N/A% and an ROE of 8.75%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.44 before investing.

How does Ambey Laboratories Ltd compare with its industry peers?

Ambey Laboratories Ltd competes with major peers in the Pesticides & Agrochemicals. Investors should compare AMBEY's P/E of 25.31x and ROE of 8.75% against the industry averages to determine its competitive standing.

What is the P/E ratio of AMBEY and what does it mean?

AMBEY has a P/E ratio of 25.31x compared to the industry average of 29.36x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹25 for every ₹1 of annual earnings.

How is AMBEY performing according to Bull Run's analysis?

AMBEY has a Bull Run fundamental score of 21.6/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does AMBEY belong to?

AMBEY operates in the Pesticides & Agrochemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Ambey Laboratories Ltd.

What is Return on Equity (ROE) and why is it important for AMBEY?

AMBEY has an ROE of 8.75%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Ambey Laboratories Ltd generates profits from shareholders' equity.

How is AMBEY's debt-to-equity ratio and what does it indicate?

AMBEY has a debt-to-equity ratio of 0.44, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.

What is AMBEY's dividend yield and is it a good dividend stock?

AMBEY offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has AMBEY grown over the past 5 years?

AMBEY has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in AMBEY and why does it matter?

Promoters hold 70.15% of AMBEY shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is AMBEY's market capitalization category?

AMBEY has a market capitalization of ₹112 crores, placing it in the Small-cap category.

How volatile is AMBEY stock?

AMBEY has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for AMBEY?

AMBEY has a 52-week high of ₹N/A and low of ₹N/A.

What is AMBEY's operating profit margin trend?

AMBEY has a 5-year average Operating Profit Margin (OPM) of 8.92%, indicating the company's operational efficiency.

How is AMBEY's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 0.78% and YoY Profit Growth of -11.78%.

What is the institutional holding pattern in AMBEY?

AMBEY has FII holding of 0.00% and DII holding of 1.96%. Significant institutional holding often suggests professional confidence in the stock.